High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases
暂无分享,去创建一个
[1] M. Andreani,et al. The cure of thalassemia by bone marrow transplantation. , 2002, Blood reviews.
[2] R. Soiffer,et al. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. , 2001, Blood.
[3] A. Nowak‐Wegrzyn,et al. Fatal warm autoimmune hemolytic anemia resulting from IgM autoagglutinins in an infant with severe combined immunodeficiency. , 2001, Journal of pediatric hematology/oncology.
[4] F. Preijers,et al. Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients , 2000, Bone Marrow Transplantation.
[5] F. Locatelli,et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. , 2000, Blood.
[6] M. Grever,et al. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies , 1998, Bone Marrow Transplantation.
[7] C Anasetti,et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. , 1998, The New England journal of medicine.
[8] S. Mackinnon,et al. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. , 1998, Blood.
[9] F. Preijers,et al. Outcome of transplantation for standard‐risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen , 1997, British journal of haematology.
[10] J. Davis,et al. CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity. , 1997, Transplantation proceedings.
[11] E. Copelan,et al. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy. , 1996, Bone marrow transplantation.
[12] M. Andreani,et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. , 1996, Blood.
[13] K. Schepers,et al. The clinical use of elutriation and positive stem cell selection columns to engineer the lymphocyte and stem cell composition of the allograft. , 1994, Progress in clinical and biological research.
[14] A. Nademanee,et al. Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. , 1993, The New England journal of medicine.
[15] G. Lucarelli,et al. Bone marrow transplantation in class 2 thalassemia patients. , 1993, Bone marrow transplantation.
[16] G. Lucarelli,et al. Bone marrow transplantation in class 1 thalassemia patients. , 1993, Bone marrow transplantation.
[17] M. Pepe,et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. , 1991, Transplantation.
[18] J. Wagner,et al. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells , 1990, Nature.
[19] J. Wagner,et al. Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial. , 1990, Blood.
[20] J. Raemaekers,et al. Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation. , 1990, Blood.
[21] B. Shank,et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants , 1989 .
[22] Brenda,et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. , 1989, Blood.
[23] H. Deeg,et al. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. , 1988, Bone marrow transplantation.
[24] J. Wagner,et al. Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion. , 1988, Experimental hematology.
[25] A. Donnenberg,et al. Implementation of a semiclosed large scale counterflow centrifugal elutriation system , 1987, Journal of clinical apheresis.
[26] A. Donnenberg,et al. Large scale separation of human bone marrow by counterflow centrifugation elutriation. , 1986, Journal of immunological methods.
[27] C. Haanen,et al. Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation. , 1986, Blood.
[28] K. Wilms,et al. Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT. , 1981, Transplantation proceedings.
[29] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .